Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 359

1.

The American Joint Commission Cancer 8th Edition Prognostic Stage Including Oncotype DX® Recurrence Score: Impact on Staging of Early Breast Cancer.

O'Cearbhaill R, Gannon JM, Prichard RS, Walshe JM, McDermott E, Quinn CM.

Pathobiology. 2018 Oct 22:1-6. doi: 10.1159/000493363. [Epub ahead of print]

PMID:
30347405
2.

Expression, purification and DNA-binding properties of zinc finger domains of DOF proteins from Arabidopsis thaliana.

Moghaddas Sani H, Hamzeh-Mivehroud M, Silva AP, Walshe JL, Mohammadi SA, Rahbar-Shahrouziasl M, Abbasi M, Jamshidi O, Low JK, Dastmalchi S, Mackay JP.

Bioimpacts. 2018;8(3):167-176. doi: 10.15171/bi.2018.19. Epub 2018 Jan 28.

3.

Demonstration of P-selectin expression and potential function in human corneal epithelial cells.

Gillies PJ, Richardson NA, Walshe J, Stephenson SA, Dawson RA, Harkin DG.

Exp Eye Res. 2018 Nov;176:196-206. doi: 10.1016/j.exer.2018.07.018. Epub 2018 Jul 17.

PMID:
30025918
4.

Impact of timing of trastuzumab initiation on long-term outcome of patients with early-stage HER2-positive breast cancer: the "one thousand HER2 patients" project.

Gullo G, Walsh N, Fennelly D, Bose R, Walshe J, Tryfonopoulos D, O'Mahony K, Hammond L, Silva N, McDonnell D, Ballot J, Quinn C, McDermott EW, Evoy D, Prichard R, Geraghty J, Amstrong J, Crown J.

Br J Cancer. 2018 Aug;119(3):374-380. doi: 10.1038/s41416-018-0114-x. Epub 2018 May 18.

PMID:
29773838
5.

Where youth matters-clinicopathologic characteristics and emerging trends in treatment and outcomes in young Irish women with breast cancer.

Greally M, Kielty J, Watson GA, Das G, Malouf C, McSorley L, Coleman N, Quinn C, McDermott EW, Gullo G, Crown J, Prichard RS, Kelly CM, Walshe JM.

Ir J Med Sci. 2018 May 15. doi: 10.1007/s11845-018-1832-z. [Epub ahead of print]

PMID:
29766409
6.

Cultivation of corneal endothelial cells from sheep.

Al Abdulsalam NK, Barnett NL, Harkin DG, Walshe J.

Exp Eye Res. 2018 Aug;173:24-31. doi: 10.1016/j.exer.2018.04.011. Epub 2018 Apr 20.

PMID:
29680447
7.

A potential role for Eph receptor signalling during migration of corneal endothelial cells.

Walshe J, Richardson NA, Al Abdulsalam NK, Stephenson SA, Harkin DG.

Exp Eye Res. 2018 May;170:92-100. doi: 10.1016/j.exer.2018.02.017. Epub 2018 Feb 21.

PMID:
29476773
8.

Mounting of Biomaterials for Use in Ophthalmic Cell Therapies.

Harkin DG, Dunphy SE, Shadforth AMA, Dawson RA, Walshe J, Zakaria N.

Cell Transplant. 2017 Nov;26(11):1717-1732. doi: 10.1177/0963689717723638.

9.

A randomized phase II study evaluating different maintenance schedules of nab-paclitaxel in the first-line treatment of metastatic breast cancer: final results of the IBCSG 42-12/BIG 2-12 SNAP trial.

Gennari A, Sun Z, Hasler-Strub U, Colleoni M, Kennedy MJ, Von Moos R, Cortés J, Vidal MJ, Hennessy B, Walshe J, Parraga KA, Ribi K, Bernhard J, Murillo SM, Pagani O, Barbeaux A, Borstnar S, Rabaglio-Poretti M, Maibach R, Regan MM, Jerusalem G; International Breast Cancer Study Group, Cancer Trials Ireland and SOLTI Group.

Ann Oncol. 2018 Mar 1;29(3):661-668. doi: 10.1093/annonc/mdx772.

PMID:
29228091
10.

Reply to Liu et al.: Yin and yang of PTEN regulation.

Johnsson P, Lister N, Shevchenko G, Walshe J, Ataide SF, Morris KV.

Proc Natl Acad Sci U S A. 2017 Dec 5;114(49):E10512-E10513. doi: 10.1073/pnas.1718258114. Epub 2017 Nov 14. No abstract available.

11.

The molecular dynamics of long noncoding RNA control of transcription in PTEN and its pseudogene.

Lister N, Shevchenko G, Walshe JL, Groen J, Johnsson P, Vidarsdóttir L, Grander D, Ataide SF, Morris KV.

Proc Natl Acad Sci U S A. 2017 Sep 12;114(37):9942-9947. doi: 10.1073/pnas.1621490114. Epub 2017 Aug 28.

12.

Impact of somatic PI3K pathway and ERBB family mutations on pathological complete response (pCR) in HER2-positive breast cancer patients who received neoadjuvant HER2-targeted therapies.

Toomey S, Eustace AJ, Fay J, Sheehan KM, Carr A, Milewska M, Madden SF, Teiserskiene A, Kay EW, O'Donovan N, Gallagher W, Grogan L, Breathnach O, Walshe J, Kelly C, Moulton B, Kennedy MJ, Gullo G, Hill AD, Power C, Duke D, Hambly N, Crown J, Hennessy BT.

Breast Cancer Res. 2017 Jul 27;19(1):87. doi: 10.1186/s13058-017-0883-9.

13.

Comparison of Oncotype DX® Recurrence Score® with other risk assessment tools including the Nottingham Prognostic Index in the identification of patients with low-risk invasive breast cancer.

Cotter MB, Dakin A, Maguire A, Walshe JM, Kennedy MJ, Dunne B, Riain CÓ, Quinn CM.

Virchows Arch. 2017 Sep;471(3):321-328. doi: 10.1007/s00428-017-2184-1. Epub 2017 Jul 14.

PMID:
28707056
14.

History of Wilson disease: a personal account.

Walshe JM.

Handb Clin Neurol. 2017;142:1-5. doi: 10.1016/B978-0-444-63625-6.00001-X.

PMID:
28433095
15.

A review of therapy-related myelodysplastic syndromes and acute myeloid leukaemia (t-MDS/AML) in Irish patients: a single centre experience.

Maung SW, Burke C, Hayde J, Walshe J, McDermott R, Desmond R, McHugh J, Enright H.

Hematology. 2017 Jul;22(6):341-346. doi: 10.1080/10245332.2017.1286539. Epub 2017 Feb 15.

PMID:
28196450
16.

Palbociclib and Letrozole in Advanced Breast Cancer.

Finn RS, Martin M, Rugo HS, Jones S, Im SA, Gelmon K, Harbeck N, Lipatov ON, Walshe JM, Moulder S, Gauthier E, Lu DR, Randolph S, Diéras V, Slamon DJ.

N Engl J Med. 2016 Nov 17;375(20):1925-1936.

17.

Optimization of Corneal Epithelial Progenitor Cell Growth on Bombyx mori Silk Fibroin Membranes.

Hogerheyde TA, Suzuki S, Walshe J, Bray LJ, Stephenson SA, Harkin DG, Richardson NA.

Stem Cells Int. 2016;2016:8310127. doi: 10.1155/2016/8310127. Epub 2016 Aug 28.

18.

Evaluation of the AlgerBrush II rotating burr as a tool for inducing ocular surface failure in the New Zealand White rabbit.

Li FJ, Nili E, Lau C, Richardson NA, Walshe J, Barnett NL, Cronin BG, Hirst LW, Schwab IR, Chirila TV, Harkin DG.

Exp Eye Res. 2016 Jun;147:1-11. doi: 10.1016/j.exer.2016.04.005. Epub 2016 Apr 13.

PMID:
27085211
19.

Late cardiac effects of chemotherapy in breast cancer survivors treated with adjuvant doxorubicin: 10-year follow-up.

Murtagh G, Lyons T, O'Connell E, Ballot J, Geraghty L, Fennelly D, Gullo G, Ledwidge M, Crown J, Gallagher J, Watson C, McDonald KM, Walshe JM.

Breast Cancer Res Treat. 2016 Apr;156(3):501-506. doi: 10.1007/s10549-016-3781-4. Epub 2016 Apr 9.

PMID:
27060913
20.

Economic impact of 21-gene recurrence score testing on early-stage breast cancer in Ireland.

Smyth L, Watson G, Walsh EM, Kelly CM, Keane M, Kennedy MJ, Grogan L, Hennessy BT, O'Reilly S, Coate LE, O'Connor M, Quinn C, Verleger K, Schoeman O, O'Reilly S, Walshe JM.

Breast Cancer Res Treat. 2015 Oct;153(3):573-82. doi: 10.1007/s10549-015-3555-4. Epub 2015 Sep 12.

PMID:
26364296
21.

Wilson disease: a most unusual patient.

Walshe JM.

QJM. 2016 Feb;109(2):117-8. doi: 10.1093/qjmed/hcv142. Epub 2015 Aug 18. No abstract available.

PMID:
26286547
22.

Attitudes to genetically modified food over time: How trust in organizations and the media cycle predict support.

Marques MD, Critchley CR, Walshe J.

Public Underst Sci. 2015 Jul;24(5):601-18. doi: 10.1177/0963662514542372. Epub 2014 Jul 24.

PMID:
25063421
23.

Serial explant culture provides novel insights into the potential location and phenotype of corneal endothelial progenitor cells.

Walshe J, Harkin DG.

Exp Eye Res. 2014 Oct;127:9-13. doi: 10.1016/j.exer.2014.07.002. Epub 2014 Jul 14.

PMID:
25035050
24.

Central nervous system regeneration.

Walshe JM.

QJM. 2014 Aug;107(8):687. doi: 10.1093/qjmed/hcu120. Epub 2014 Jun 6. No abstract available.

PMID:
24906972
25.

Ubiquitin fusion constructs allow the expression and purification of multi-KOW domain complexes of the Saccharomyces cerevisiae transcription elongation factor Spt4/5.

Blythe A, Gunasekara S, Walshe J, Mackay JP, Hartzog GA, Vrielink A.

Protein Expr Purif. 2014 Aug;100:54-60. doi: 10.1016/j.pep.2014.05.005. Epub 2014 May 21.

PMID:
24859675
26.

The Kayser-Fleischer ring.

Walshe JM.

Br J Hosp Med (Lond). 2014 Mar;75(3):C38-9. No abstract available.

PMID:
24621667
27.

The acute haemolytic syndrome in Wilson's disease--a review of 22 patients.

Walshe JM.

QJM. 2013 Nov;106(11):1003-8. doi: 10.1093/qjmed/hct137. Epub 2013 Jul 9.

PMID:
23842488
28.

The structure of the neisserial lipooligosaccharide phosphoethanolamine transferase A (LptA) required for resistance to polymyxin.

Wanty C, Anandan A, Piek S, Walshe J, Ganguly J, Carlson RW, Stubbs KA, Kahler CM, Vrielink A.

J Mol Biol. 2013 Sep 23;425(18):3389-402. doi: 10.1016/j.jmb.2013.06.029. Epub 2013 Jun 28.

PMID:
23810904
29.

Arterio-venous fistula buttonhole cannulation technique: a retrospective analysis of infectious complications.

O'Brien FJ, Kok HK, O'Kane C, McWilliams J, O'Kelly P, Collins P, Walshe J, Magee CC, Denton MD, Conlon PJ.

Clin Kidney J. 2012 Dec;5(6):526-9. doi: 10.1093/ckj/sfs135. Epub 2012 Oct 26.

30.

The "curse of the registrar".

Walshe J.

BMJ. 2012 Sep 18;345:e6039. doi: 10.1136/bmj.e6039. No abstract available.

PMID:
22990998
31.

Acute renal failure secondary to tuberculosis: a diagnostic challenge.

Khilji SI, Kok HK, Wong L, Dorman AM, Walshe JJ.

Case Rep Nephrol. 2012;2012:510179. doi: 10.1155/2012/510179. Epub 2012 Feb 22.

32.

Serum 'free' copper in Wilson disease.

Walshe JM.

QJM. 2012 May;105(5):419-23. doi: 10.1093/qjmed/hcr229. Epub 2012 Feb 1.

PMID:
22139498
33.

Reproductive health in Irish female renal transplant recipients.

Kennedy C, Hussein W, Spencer S, Walshe J, Denton M, Conlon PJ, Magee C.

Ir J Med Sci. 2012 Mar;181(1):59-63. doi: 10.1007/s11845-011-0767-4. Epub 2011 Oct 28.

PMID:
22033814
34.

Renal histology in the elderly: indications and outcomes.

Brown CM, Scheven L, O'Kelly P, Dorman AM, Walshe JJ.

J Nephrol. 2012 Mar-Apr;25(2):240-4. doi: 10.5301/JN.2011.8447.

PMID:
21725922
35.

The pattern of urinary copper excretion and its response to treatment in patients with Wilson's disease.

Walshe JM.

QJM. 2011 Sep;104(9):775-8. doi: 10.1093/qjmed/hcr073. Epub 2011 May 27.

PMID:
21622540
36.

A prospective study of hepatitis B vaccination - a comparison of responders versus nonresponders.

Brown CM, Donlon S, O'Kelly P, Casey AM, Collier C, Conlon PJ, Walshe JJ.

Ren Fail. 2011;33(3):276-9. doi: 10.3109/0886022X.2011.559300.

PMID:
21401350
37.

Warfarin use in hemodialysis patients: what is the risk?

Phelan PJ, O'Kelly P, Holian J, Walshe JJ, Delany C, Slaby J, Winders S, O'Toole D, Magee C, Conlon PJ.

Clin Nephrol. 2011 Mar;75(3):204-11.

PMID:
21329630
38.

NUT midline carcinoma in a young woman.

Teo M, Crotty P, O'Sullivan M, French CA, Walshe JM.

J Clin Oncol. 2011 Apr 20;29(12):e336-9. doi: 10.1200/JCO.2010.32.7486. Epub 2011 Jan 24. No abstract available.

PMID:
21263084
39.

Bilateral renal cortical necrosis in meningococcal meningitis.

Kennedy C, Khilji S, Dorman A, Walshe J.

Case Rep Nephrol. 2011;2011:274341. doi: 10.1155/2011/274341. Epub 2011 Nov 22.

40.

Penicillamine neurotoxicity: an hypothesis.

Walshe JM.

ISRN Neurol. 2011;2011:464572. doi: 10.5402/2011/464572. Epub 2011 Jul 21.

41.

A successful pregnancy in a dialysis patient with renal cortical necrosis.

Brown CM, O'Kane C, McDonnell B, Garvey JP, Byrne P, Magee C, Walshe JJ.

Nephrology (Carlton). 2010 Oct;15(7):720. No abstract available.

PMID:
21069918
42.

Steroid withdrawal in renal transplant patients: the Irish experience.

Phelan PJ, Moran AM, O'Kelly P, Heng PY, Yussof SM, Walshe JJ, Magee C, Conlon PJ.

Ir J Med Sci. 2011 Jun;180(2):429-33. doi: 10.1007/s11845-010-0626-8. Epub 2010 Oct 29.

PMID:
21046471
43.

The impact of peritransplant warfarin use on renal transplant outcome.

Connaughton DM, Phelan PJ, Scheult J, Ma'ayeh M, O'Kelly P, Walshe JJ, Magee C, Little D, Hickey D, Slaby J, Conlon PJ.

J Nephrol. 2010 Sep-Oct;23(5):587-92.

PMID:
20540039
44.

Monitoring copper in Wilson's disease.

Walshe JM.

Adv Clin Chem. 2010;50:151-63. Review.

PMID:
20521445
45.

Encapsulating peritoneal sclerosis: experience of a tertiary referral center.

Phelan PJ, Walshe JJ, Al-Aradi A, Garvey JP, Finnegan K, O'Kelly P, McWilliams J, Ti JP, Morrin MM, Morgan N, Conlon PJ.

Ren Fail. 2010 May;32(4):459-63. doi: 10.3109/08860221003658274.

PMID:
20446784
46.

The eye in Wilson disease.

Walshe JM.

QJM. 2011 May;104(5):451-3. doi: 10.1093/qjmed/hcq065. Epub 2010 May 5. No abstract available.

PMID:
20444834
47.

Ovarian inflammatory myofibroblastic tumour fistulating on to the anterior abdominal wall.

Khan G, Treacy A, Garvey JP, Png B, Walshe J, Leader M, Byrne P.

J Obstet Gynaecol. 2010 Jan;30(1):74-6. doi: 10.3109/01443610903315637. No abstract available.

PMID:
20121520
48.

Long-term experience of plasmapheresis in antibody-mediated rejection in renal transplantation.

Brown CM, Abraham KA, O'Kelly P, Conlon PJ, Walshe JJ.

Transplant Proc. 2009 Nov;41(9):3690-2. doi: 10.1016/j.transproceed.2009.06.197.

PMID:
19917368
49.

Left versus right deceased donor renal allograft outcome.

Phelan PJ, Shields W, O'Kelly P, Pendergrass M, Holian J, Walshe JJ, Magee C, Little D, Hickey D, Conlon PJ.

Transpl Int. 2009 Dec;22(12):1159-63.

PMID:
19891044
50.

Trimethoprim-sulfamethoxazole induced acute interstitial nephritis in renal allografts; clinical course and outcome.

Garvey JP, Brown CM, Chotirmall SH, Dorman AM, Conlon PJ, Walshe JJ.

Clin Nephrol. 2009 Nov;72(5):331-6.

PMID:
19863874

Supplemental Content

Loading ...
Support Center